Ultragenyx Pharmaceutical reported $796.42M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Aptinyx Inc APTX:US $ 77.48M 17.27M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Epizyme EPZM:US $ 11.12M 31.81M
Esperion Therapeutics ESPR:US $ -249040000 52.1M
Insmed INSM:US $ 119.88M 290.59M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Kyowa Hakko Kirin 4151:JP Y 744453M 7291M
Macrogenics MGNX:US $ 178.21M 61.4M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Moderna Inc MRNA:US 17.08B 2.93B
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Ptc Therapeutics PTCT:US $ -90.58M 92.02M
Puma Biotechnology PBYI:US $ 7.14M 9.59M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Vital Therapies VTL:US $ 137.96M 10.85M
Xoma XOMA:US $ 139.92M 1.95M